Back to top

Tale of the Tape

Arena Pharmaceuticals was a big mover last session, as the company saw its shares jump nearly 11% on the day. This surge can be attributable to solid volume with far more shares changing hands than in a normal session. This broke the recent trend of the company, as the stock is now trading above the volatile price range of $4.08 to $4.75 in the past one-month time frame.

In the last 30 days, the company did not witness any estimate revisions and the Zacks Consensus Estimate has hit a plateau. However, the recent price action is encouraging, so make sure to keep a close watch on this firm in the near future.

Arena Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better performing biopharmaceutical stocks include Heska Corporation , Actelion Ltd. and AMAG Pharmaceuticals, Inc. . All these stocks hold a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Please login to Zacks.com or register to post a comment.